Alcohol, ischemic heart disease, and the French paradox

Coronary Artery Disease

Volumn 8, Issue 10, 1997, Pages 645-649

  Constant, Jules ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Alcohol; Coronary disease; Flavonoids; Ischemic heart disease; Quercetin; Resveratrol

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; FLAVONOID; HIGH DENSITY LIPOPROTEIN;

ALCOHOL CONSUMPTION; ARTICLE; CORONARY ARTERY DISEASE; FRUIT JUICE; GRAPE; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; STROKE; WINE;

EID: 0031471548     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199710000-00007     Document Type: Article

References (52)

1. Klatsky AL, Friedman GD, Siegelaub AB: Alcohol consumption before myocardial infarction: results from the Kaiser-Permanente Epidemiologic Study of Myocardial Infarction. Ann Intern Med 1974, 81:294-301.
2. Klatsky AL, Friedman GD, Siegelaub AB, Gerard HJ: Alcohol consumption and blood pressure. Kaiser-Permanente Health Examination Data. N Engl J Med 1977, 296:1154-1159.
3. Dyer AR, Stamler J, Oglesby P, Berkson DM, Shekelle RB, Lepper MH, et at: Alcohol, cardiovascular risk factors and mortality: the Chicago experience. Circulation 1981, 64 (suppl III):20-26.
4. Howes LG, Reid JL: Decreased vascular responsiveness to noradrenaline following regular ethanol consumption. Br J Clin Pharmacol 1985, 20:669-674.
5. Lowry DR, Mead LA, Dannenberg AL, King MJ: Alcohol consumption and incidence of hypertension. The John Hopkins Precursors Study [abstract]. Circulation 1995, 92:619.
6. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, et al.: Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 1996, 27:1065-1072.
7. Yano K, Rhoads GG. Kagan A: Coffee, alcohol, and risk of coronary heart disease among Japanese men in Hawaii. N Engl J Med 1977, 297:405-409.
8. Kagan A, Yano K, Rhoads GG, McGee DL: Alcohol and cardiovascular disease. The Hawaiian experience. Circulation 1981, 64 (suppl II):64.
9. Gordon T, Kannel WB: Drinking habits and cardiovascular disease. The Framingham Study. Am Heart J 1963, 105:667-673.
10. Colditz GA, Branch LG, Lipnick RJ, Willett WC, Rosner B, Posner B: Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J 1985, 109:886-890.
11. Shaper AG, Phillips AN, Pocock SJ, Walker M: Alcohol and ischaemic heart disease in middle aged British men. BMJ 1987, 294:733-736.
12. Nakamura Y, Kawai C, Kmoshita M, Moss AJ: Moderate alcohol intake and outcome after an acute coronary event Circulation 1995, 92 (suppl I):708.
13. Paul O, Leppes MH, Philan WH: A longitudinal study of coronary heart disease. Circulation 1963, 28:20-31.
14. Doyle JT, Heslin AS, Hilleboe HE: A prospective study of degenerative cardiovascular disease in Albany. Lancet 1966, ii:553-559.
15. Tibblin G, Wilhelmsen L, Werko L: Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol 1975, 35:514-522.
16. Hrubec Z, Cederlof R, Friberg L: Background of angina pectoris: social and environmental factors in relation to smoking. Am J Epidemiol 1976, 103:16-29.
17. Hennekens CH, Rosner B, Cole DS: Daily alcohol consumption and fatal coronary heart disease [abstract]. Am J Epidemiol 1978, 107:197.
18. Castelli WP: How many drinks per day? JAMA 1979, 242:2000.
19. Evans DA, Willett WC, Hennekens CH: Alcohol and coronary heart disease. Am Heart J 1980, 100:583-584.
20. Stampfer MJ, Colditz GA, Willett WC: A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988, 319:273.
21. Taskinen M-R, Nikkila EA, Valimaki M, Sane T, Kuusi T, Kesaniemi A, et al.: Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J 1987, 113:258-264.
22. Johansson BG, Nilsson E: Alcohol consumption and HDL [letter]. N Engl J Med 1978, 298:633.
23. Deveny P, Robinson GM, Kapur BM, Roncari DAK: High-density lipoprotein cholesterol in male alcoholics and without severe liver disease. Am J Med 1981, 71:589-594.
24. Belfrage P, Berg B, Hagerstrand I: Alterations in lipid metabolism in healthy volunteers during long-term ethanol. Eur J Clin Invest 1977, 7:127-131.
25. Castelli WP, Hjortland MC, Kaga A, Doyle JT, Hames GC, Hulley SN, et al.: Alcohol and blood lipids. Lancet 1977, 2:153-155.
26. Moore RD, Smith CR, Kwiterovich PO, Pearson TA: Effect of low-dose alcohol use vs abstention on plasma apoprotein Al and B levels: a prospective, randomized trial. Circulation 1985, 82 (suppl III):453.
27. Buring JE, Willett W, Goldhaber SZ, Mayrent SL, Breslow J, Hennekens C, and the Boston Area Health Study Research Group: Alcohol, HDL, and nonfatal MI. Circulation 1983, 68 (suppl III):227.
28. Avogara P, Cazzolato G, Belussi F, Bittolo BG: Altered apolipoprotein composition of HDL 2 and HDL 3 in chronic alcoholics. Artery 1982, 10:317-328.
29. Haskell WL, Camargo JC, Willimas PT, Vranizan KM: The effect of cessation and resumption of moderate alcohol intake on HDL subfractions. N Engl J Med 1984, 310:805.
30. Hendriks HF, Veenstra J, Veithuis-teWierik EJM, Schafsma G, Kluft C: Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ 1994, 308:1003-1006.
31. Millikan CH, Siekert RG, Shick RM: Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Proc Staff Meet Mayo Clinic 1955, 30:116.
32. Evans A: Dr Black's favourite disease. Br Heart J 1995, 74:696-697.
33. St Leger AS, Cochrane AL, Moore F: Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979, 1:1017-1020.
34. Artaud-Wild SM, Connor SL, Sexton G, Connor WE: Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. Circulation 1993, 88:2771-2779.
35. Klatsky AL, Armstrong MA: Alcoholic beverage choice and risk of coronary heart disease mortality. Am J Cardiol 1993, 71:469.
36. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ: Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ 1996, 312:731-736.
37. Klatsky AL, Armstrong MA, Kipp H: Correlation of alcoholic beverage preference of persons who choose wine, liquor, or beer. Br J Addiction 1990, 85:1279-1289.
38. Kuhnan J: The flavonoids. World Rev Nutr Diet 1976, 24:117-120.
39. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Krombout D: Dietary antioxidant flavonoids and risk of coronary heart disease. The Zuphen Elderly Study. Lancet 1993, 342:1007-1011.
40. Frankel EN, Waterhouse AL, Kinsella JE: Inhibition of human LDL oxidation of resveratrol. Lancet 1993, 341:1103-1104.
41. Cishek MB, Galloway MT, Karim M, Kappagoda T: Red wine induces endothelium dependent relaxation. Circulation 1996, 94 (suppl 1): 105.
42. Renaud S, deLorgeral M: The French paradox: dietary factors and cigarette smoking related health problems. Ann NY Acad Sci 1993, 686:299-309.
43. Gronbaek M, Deis A, Sorensen TIA, Becker U, Schnohr P, Jensen G: Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1995, 310:1165-1169.
44. Stanford JL, Weiss NS, Voight LF: Combined estrogen and progestins and risk of breast cancer. JAMA 1995, 274:137-142.
45. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
46. Fuhrman B, Lavy A, Aviram M: Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995, 61:549-554.
47. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE: Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341:454-457.
48. Folts JD, Demrow HS, Slane PR: Two glasses of red but not white wine inhibits ex-vivo platelet aggregation and increases bleeding time in human volunteers [abstract]. J Am Coll Cardiol 1994, 1A:49.
49. Demrow HS, Folts JD: Gastric or IV administration of French red wine but not white wine inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries [abstract]. J Am Coll Cardiol 1994, 1A:49.
50. Pattichis K, Louca LL, Jarman J, Sandier M, Glover V: Phenolic substances in red wine and release of platelet 5-hydroxytryptamine [letter]. Lancet 1993, 341:1104.
51. Ho CT, Chen Q, Shi H, Zhang KQ, Rosen RT: Antioxidative effect of various Chinese teas. Prevent Med 1992, 21:520-525.
52. Demrow HS, Slane PR, Folts JD: Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995, 91:1182-1188.